• Axovant shares plummet on dementia drug failure pharmatimes
    January 10, 2018
    Shares in Axovant Sciences Ltd sank almost 50 percent after investors shrank back on new of the failure of lead drug intepirdine in a mid-stage study in patients with a particular kind of dementia.
PharmaSources Customer Service